Keith J. Sullivan, Senior Vice President of Worldwide Sales at Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) disclosed today the disposal of 6,077 shares of common stock through three different transactions with unit prices ranging from $26.44 to $26.589 on November 4, 2014. Mr. Sullivan has reached the tenth sale this year, and now directly owns 104,246 shares and an additional 15,000 indirectly.
Mark J. Foley, President and Chief Executive Officer at Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) has also traded the company’s stock this year. Mr. Foley has reported eighteen sales so far this year, for a total of 124,861 shares at prices ranging from $18.00 to $26.45, and now owns a total of 580,033 shares.
Dennis Purcell’s Aisling Capital is the largest shareholding institution (amongst those we track) at Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) with close to 2.6 million shares, valued at an estimate $39.5 million, after reporting no changes at the end of the second filling period of 2014.
Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue.
Disclosure: The author, Jodor Jalit, holds no position in any stocks or funds mentioned.